Achille Iolascon

Rachel Grace, a pediatric hematologist at the Dana-Farber Boston Children’s Cancer and Blood Disorder Center, discusses advancements in understanding and treating pyruvate kinase deficiency. Achille Iolascon, a professor of medical genetics, shares insights on congenital dyserythropoietic anemias. They delve into breakthroughs in pharmacological treatments, including gene therapy, and the complexities of diagnosing inherited anemias. The conversation highlights the importance of genetic research and its potential to improve patient care and treatment outcomes.